Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2016-07-28

Clinical Trial Update: Influence of 0.75% Ropivacaine Topicalization on Emergence Agitation in Children [NA]

View source ↗

Summary

An update on a clinical trial evaluating whether topical 0.75% ropivacaine reduces emergence agitation in children with tonsillitis. The current trial status is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ropivacaine (Ropivacaine)

Snippet

Sponsor: Ajou University School of Medicine | Conditions: Tonsillitis | NA | Status: UNKNOWN